Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

PEGylated rhFGF-2 Conveys Long-term Neuroprotection and Improves Neuronal Function in a Rat Model of Parkinson's Disease.

Zhu G, Chen G, Shi L, Feng J, Wang Y, Ye C, Feng W, Niu J, Huang Z.

Mol Neurobiol. 2014 Jun 15. [Epub ahead of print]

PMID:
24930088
[PubMed - as supplied by publisher]
2.

Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.

Huang Z, Ye C, Liu Z, Wang X, Chen H, Liu Y, Tang L, Zhao H, Wang J, Feng W, Li X.

Bioconjug Chem. 2012 Apr 18;23(4):740-50. doi: 10.1021/bc200550f. Epub 2012 Apr 2.

PMID:
22433083
[PubMed - indexed for MEDLINE]
3.

Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.

Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T.

Neuroscience. 2014 Jan 31;258:385-400. doi: 10.1016/j.neuroscience.2013.11.038. Epub 2013 Nov 27.

PMID:
24291725
[PubMed - in process]
4.

Dopamine neuron stimulating actions of a GDNF propeptide.

Bradley LH, Fuqua J, Richardson A, Turchan-Cholewo J, Ai Y, Kelps KA, Glass JD, He X, Zhang Z, Grondin R, Littrell OM, Huettl P, Pomerleau F, Gash DM, Gerhardt GA.

PLoS One. 2010 Mar 18;5(3):e9752. doi: 10.1371/journal.pone.0009752.

PMID:
20305789
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Sleeman IJ, Boshoff EL, Duty S.

Neuropharmacology. 2012 Dec;63(7):1268-77. doi: 10.1016/j.neuropharm.2012.07.029. Epub 2012 Aug 10.

PMID:
22971544
[PubMed - indexed for MEDLINE]
6.
7.

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.

Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH.

Exp Neurol. 2003 Mar;180(1):93-8.

PMID:
12668152
[PubMed - indexed for MEDLINE]
8.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):155-61.

PMID:
15790539
[PubMed - indexed for MEDLINE]
9.

Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).

Herzog CD, Brown L, Kruegel BR, Wilson A, Tansey MG, Gage FH, Johnson EM Jr, Bartus RT.

Neurobiol Dis. 2013 Oct;58:38-48. doi: 10.1016/j.nbd.2013.04.011. Epub 2013 Apr 28.

PMID:
23631873
[PubMed - indexed for MEDLINE]
10.

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

Sullivan AM, Opacka-Juffry J, Blunt SB.

Eur J Neurosci. 1998 Jan;10(1):57-63.

PMID:
9753113
[PubMed - indexed for MEDLINE]
11.

Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.

Han B, Hu J, Shen J, Gao Y, Lu Y, Wang T.

Eur J Pharmacol. 2013 Aug 15;714(1-3):83-8. doi: 10.1016/j.ejphar.2013.06.011. Epub 2013 Jun 18.

PMID:
23791614
[PubMed - indexed for MEDLINE]
12.

Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.

Frank T, Klinker F, Falkenburger BH, Laage R, Lühder F, Göricke B, Schneider A, Neurath H, Desel H, Liebetanz D, Bähr M, Weishaupt JH.

Brain. 2012 Jun;135(Pt 6):1914-25. doi: 10.1093/brain/aws054. Epub 2012 Mar 16.

PMID:
22427327
[PubMed - indexed for MEDLINE]
Free Article
13.

Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion.

Timmer M, Cesnulevicius K, Winkler C, Kolb J, Lipokatic-Takacs E, Jungnickel J, Grothe C.

J Neurosci. 2007 Jan 17;27(3):459-71.

PMID:
17234579
[PubMed - indexed for MEDLINE]
Free Article
15.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
[PubMed - indexed for MEDLINE]
16.

Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.

Xue YQ, Zhao LR, Guo WP, Duan WM.

Neuroscience. 2007 May 25;146(3):1245-58. Epub 2007 Mar 23.

PMID:
17363174
[PubMed - indexed for MEDLINE]
17.

Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.

Cunningham LA, Su C.

Exp Neurol. 2002 Apr;174(2):230-42.

PMID:
11922664
[PubMed - indexed for MEDLINE]
18.

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

Youdim MB, Stephenson G, Ben Shachar D.

Ann N Y Acad Sci. 2004 Mar;1012:306-25.

PMID:
15105275
[PubMed - indexed for MEDLINE]
19.

Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease.

Voutilainen MH, Bäck S, Pörsti E, Toppinen L, Lindgren L, Lindholm P, Peränen J, Saarma M, Tuominen RK.

J Neurosci. 2009 Jul 29;29(30):9651-9. doi: 10.1523/JNEUROSCI.0833-09.2009.

PMID:
19641128
[PubMed - indexed for MEDLINE]
Free Article
20.

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.

Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.

J Neurochem. 2004 May;89(3):776-87.

PMID:
15086533
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk